
Permira walks away with Dr Martens
After months of speculation, Permira has acquired iconic footwear brand Dr Martens for £300m.
The deal sees Permira acquiring R Griggs Group, the parent company of Dr Martens, and licence in perpetuity of the brand.
Barclays facilitated the debt financing for the deal.
It was reported last week that Permira was in advanced stages to buy a 91.5% stake in the company.
Company
Established in 1960 and headquartered in Northants on the site of the original factory, Dr Martens is a globally recognised brand, being sold in 63 counties, predominantly in the US, Asia, Europe and the UK.
People
David Suddens is CEO of Dr Martens. Cheryl Potter is partner and head of the consumer sector team at Permira.
Advisors
Equity – Barclays (Financial due diligence).
Vendor – Rothschild (Corporate finance).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater